Sun, Mar 18, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

New hire for Concept Capital Markets' institutional sales team

Tuesday, July 31, 2012
Opalesque Industry Update - Concept Capital Markets, LLC has hired a team of seasoned sales professionals to complement its existing institutional sales and trading effort. Joining the firm are Edwin Leon, Scott Klym, Francis Fiolek, Michael Sepe and Peter Walsh. The team will operate from Concept Capital’s office in Greenwich, CT. The group comes to Concept Capital from Rodman & Renshaw, LLC and brings with it a great deal of experience catering to a diverse group of domestic and international institutional investors. The team honed its numerous client relationships over many years and through earlier affiliations with various well known and highly regarded investment firms.

“We are pleased to welcome Edwin, Scott, Francis, Michael and Peter to Concept Capital, and look forward to working with them to deliver to their clients the exceptional execution and operational support they’ve come to expect”, said Robert Moore, Senior Managing Director and Chief Executive Officer of the firm. “This team will complement our firm’s existing institutional sales and trading business that’s been an integral part of our firm’s growth strategy, and help us to develop a more diversified client base”, he added.

Michael Rosen, Senior Managing Director, added “we’re excited for the opportunity to introduce Concept Capital and our capabilities to the clients of our new sales team. Our mission is to deliver custody, execution and clearing, reporting solutions, and operational support that free our clients to focus on their core competencies. Our continued investments to enhance our offering have helped us to win a growing number of new client mandates and sustain a very high client retention rate.”

Press release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t